1[1]Ohkbo Y,Kishikawa H,Araki E,et al.Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus:a randomized prospective-year study.Diabetes Res Clin Pract,1995,28(3):103.
2[2]UK Prospective Diabetes Study Group.Intensive blood glucose control with sulphonylures or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes:UKPDS 33.Lancet,1998,352(7):837.
3[3]Owens DR,Luzio SD,Ismail I,et al.Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with 2 diabetes.Diabetes Care,2000,23:513-523.
4[4]Polonsky KS.Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.N Eng J Med,1988,318:1 213-1 239.
5[5]Jefebvre PJ,Scheen AI.The postprandial state risk of cardiovascular disease.Diabet Med,1998,15 Suppl 14:s63-s68.
7[7]Moses RG,Gomis R,Frandsen KB,et al.Flexible meal-related dosing with repaglinide facilitates glycemic control in therapy-native type 2 diabetes.Diabetes Care 2001,24(1):11-15.
